Copyright Reports & Markets. All rights reserved.

Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Allogeneic Mesenchymal Stem Cells
    • 1.2.3 Bone Marrow Transplant
    • 1.2.4 Adipose Tissue Stem Cells
  • 1.3 Market by Application
    • 1.3.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Specialty Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Perspective (2016-2027)
  • 2.2 Rheumatoid Arthritis Stem Cell Therapy Growth Trends by Regions
    • 2.2.1 Rheumatoid Arthritis Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Rheumatoid Arthritis Stem Cell Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Rheumatoid Arthritis Stem Cell Therapy Industry Dynamic
    • 2.3.1 Rheumatoid Arthritis Stem Cell Therapy Market Trends
    • 2.3.2 Rheumatoid Arthritis Stem Cell Therapy Market Drivers
    • 2.3.3 Rheumatoid Arthritis Stem Cell Therapy Market Challenges
    • 2.3.4 Rheumatoid Arthritis Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Revenue
    • 3.1.1 Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Rheumatoid Arthritis Stem Cell Therapy Revenue
  • 3.4 Global Rheumatoid Arthritis Stem Cell Therapy Market Concentration Ratio
    • 3.4.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Stem Cell Therapy Revenue in 2020
  • 3.5 Rheumatoid Arthritis Stem Cell Therapy Key Players Head office and Area Served
  • 3.6 Key Players Rheumatoid Arthritis Stem Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into Rheumatoid Arthritis Stem Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatoid Arthritis Stem Cell Therapy Breakdown Data by Type

  • 4.1 Global Rheumatoid Arthritis Stem Cell Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Rheumatoid Arthritis Stem Cell Therapy Breakdown Data by Application

  • 5.1 Global Rheumatoid Arthritis Stem Cell Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size (2016-2027)
  • 6.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
    • 6.2.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2027)
  • 6.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
    • 6.3.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2027)
  • 6.4 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
    • 6.4.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size (2016-2027)
  • 7.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
    • 7.2.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
    • 7.3.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
    • 7.4.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size (2016-2027)
  • 9.2 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
    • 9.2.1 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
    • 9.3.1 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
    • 9.4.1 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Mesoblast
    • 11.1.1 Mesoblast Company Details
    • 11.1.2 Mesoblast Business Overview
    • 11.1.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.1.4 Mesoblast Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.1.5 Mesoblast Recent Development
  • 11.2 Roslin Cells
    • 11.2.1 Roslin Cells Company Details
    • 11.2.2 Roslin Cells Business Overview
    • 11.2.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.2.4 Roslin Cells Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.2.5 Roslin Cells Recent Development
  • 11.3 Regeneus
    • 11.3.1 Regeneus Company Details
    • 11.3.2 Regeneus Business Overview
    • 11.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.3.4 Regeneus Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.3.5 Regeneus Recent Development
  • 11.4 ReNeuron Group
    • 11.4.1 ReNeuron Group Company Details
    • 11.4.2 ReNeuron Group Business Overview
    • 11.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.4.4 ReNeuron Group Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.4.5 ReNeuron Group Recent Development
  • 11.5 International Stem Cell Corporation
    • 11.5.1 International Stem Cell Corporation Company Details
    • 11.5.2 International Stem Cell Corporation Business Overview
    • 11.5.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.5.4 International Stem Cell Corporation Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.5.5 International Stem Cell Corporation Recent Development
  • 11.6 Takeda
    • 11.6.1 Takeda Company Details
    • 11.6.2 Takeda Business Overview
    • 11.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Introduction
    • 11.6.4 Takeda Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2016-2021)
    • 11.6.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Rheumatoid Arthritis Stem Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Allogeneic Mesenchymal Stem Cells
    Bone Marrow Transplant
    Adipose Tissue Stem Cells

    Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Mesoblast
    Roslin Cells
    Regeneus
    ReNeuron Group
    International Stem Cell Corporation

    Buy now